The purpose of this study was to assess the efficacy of mammography of breast cancer in women less than 30 years old. A retrospective record review revealed 47 breast cancers in 45 women age 29 and younger who had preoperative mammography. Patients ranged in age from 22 to 29 years (mean ...
30 January 2025 | Open Access Stroma-derived Dickkopf-1 contributes to the suppression of NK cell cytotoxicity in breast cancer Elevated levels of Dickkopf-1 (DKK1), a soluble inhibitor of the Wnt/β-catenin pathway, are associated with poor prognosis in patients with breast cancer. Here ...
Age at the time of diagnosis is broken into two groups: people under 50 and those 50 and older. These numbers are: Localized breast cancer: stage IA (pronounced “stage 1-A”), some IIA (“stage 2-A”), and some IIB (“stage 2-B”) Younger than 50: 97% 50 and up: 99% ...
Symptoms of breast cancer include: a lump or thickening in the breast or under the arm a clear or bloody discharge from the nipple crusting or scaling of the nipple a nipple that no longer sticks out (inverted) redness or swelling of the breast ...
Breast cancer is a leading cause of cancer death in women. Sleep has been linked with mortality among cancer-free population; however, its association with survival among women with breast cancer is understudied. Methods: Breast cancer patients (N=3682) reported their average sleep duration post ...
At least 10% of premenopausal triple negative breast cancer patients have BRCA1 mutations. Several researchers have suggested that all women under 50 with triple negative disease should be tested, even in the absence of a family history. However, many women without familial breast cancer would not...
Advanced breast cancers represent a major therapeutic challenge due to their refractoriness to treatment. Cancer-associated fibroblasts (CAFs) are the most abundant constituents of the tumor microenvironment and have been linked to most hallmarks of canc
NEW YORK (Reuters) - The pink ribbon symbol of breast cancer awareness is now 30 years old. Co-created by businesswoman Evelyn Lauder, the ribbon reminds women to get medical checkups and appears on products sold with a promise that part of the proceeds will be donated to support bre...
The FDA and Eagle Pharmaceuticals have agreed on the next steps for the development of EA-114, an estrogen receptor antagonist and novel formulation of fulvestrant used in the treatment of postmenopausal women with breast cancer.
Breast cancer in women under 30 years of age through the comparison of two breast cancer patient age groups: patients under the age of 30 (Group A) and premenopausal patients aged 45-49 (Group B... F Tabbane,A May,M Hachiche,... - 《Breast Cancer Res Treat》 被引量: 164发表: ...